INDEPENDENT THINKING. TRACEABLE EVIDENCE.Research edition · 29 October 2026
Modern DosingTHE PRACTITIONER’S PERSPECTIVEA clearer view of
the peptide economy ↗
The provider file / Dossier 269
RESEARCH DOSSIER / NOT AN ENDORSEMENT

PepScribe

A dated business research record, with the original field-level evidence labels kept intact.

Source snapshot: 2026-10-29. “Verified” below is the source dataset author’s label—not an independent license, safety, quality or clinical audit by Modern Dosing. These pages are excluded from search indexing until reviewed.
Positioning & service claimsverified

'Peptides aren't new. Access to them is.' LegitScript-certified, BBB-accredited (rated A) healthcare merchant. Compounded in the USA by licensed 503A pharmacies and FDA-registered facilities; 'no hidden overseas supply chain.' No membership fees; 24-hour clinician review; cancel anytime.

Audienceread

Our read: US adults seeking weight management (GLP-1 incl. oral formats), hormone therapy (TRT/HRT), thyroid and sexual-health treatments at below-boutique-clinic prices. No targeting inferred.

Pricing & termssnapshot

Semaglutide plans starting from $79/month (no membership fee). Other plan prices not captured in this pass.

Clinical relationshipspartial

US-licensed clinicians review within 24 hours and write protocols; labs ordered if needed. Clinician network and medical-group entity not named on pages reviewed.

Pharmacy & fulfillmentpartial

Filled by US-licensed 503A pharmacies; plain packaging; most orders ship within 72 hours of approval. Pharmacy names not disclosed on pages reviewed.

Advertising snapshotpartial

Google lookup displayed 0 ads (US, last 30 days) on 20 Oct 2026; Meta keyword lookups ('PepScribe', 'pepscribe.com') displayed no matching ads; LinkedIn returned no results. See dated channel evidence.

Founding yearnot_found

Not found in this pass.

    Foundersnot_found

    Not found on site pages reviewed; About page names no individuals.

      Location & entity contextnot_found

      Not stated on pages reviewed.

        Search visibility samplenot_found

        Not assessed in this pass.

          THE MODERN DOSING WEEKLY

          The peptide news
          that changes your week.

          Evidence-backed developments. The moves that matter. What each means for your practice or business—in one weekly email.